NYSE:INO

Inovio Pharmaceuticals Stock Predictions

etoro logo Buy INO
*Your capital is at risk
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
Currently predicting for Fri, 5 Jun 2026

INO Prediction Chart

INO Predictions History

Latest community submissions for INO.
Predictor Target Session Target Price Result Direction Accuracy Score
Dhruv Patel Dhruv Patel @DhruvPatel.156531
May 6, 2020 Bearish $10.47 V 1
JS JS Pro
May 5, 2020 $10.82 -91.53% $10.64 V 98.31% 1
Andreea Avramescu Andreea Avramescu @AndreeaAvramescu.138445
May 5, 2020 Bullish $10.64 X 1
May 5, 2020 Bearish $10.64 V 0
JS JS Pro
May 4, 2020 $9.75 -92.76% $11.23 V 86.82% 0
May 4, 2020 Bullish $11.23 X 1
Vishwanath Deshmukh Vishwanath Deshmukh @VishwanathDeshmukh.154798
May 4, 2020 Bearish $11.23 V 0
Samir Sohail Samir Sohail @SamirSohail.130725
May 4, 2020 $10.28 -92.37% $11.23 V 91.54% 0
JS JS Pro
Apr 30, 2020 $13.41 -90.71% $12.03 V 88.53% 1
STELLA PLA STELLA PLA @STELLAPLA.157438
Apr 30, 2020 Bearish $12.03 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for INO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT INOVIO PHARMACEUTICALS
Inovio Pharmaceuticals
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery o...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE